TABLE 3.
Observed complex lipids in the porcine brain (top 70)
| Concentration, mg/g | Found Lipids |
| 26.753 (1.3272) | GalCer d18:1/24:1(n-9) |
| 23.239 (0.4935) | SM d18:1/18:0 |
| 22.836 (4.8058) | PC 16:0/20:4(n-6,n-9,n-12.n-15) |
| 20.298 (3.8052) | PC16:0/18:1(n-9) |
| 18.579 (2.1825) | PC16:0/16:0 |
| 17.870 (1.9347) | GalCer d18:1/24:0 hydroxy |
| 17.704 (3.3133) | PC18:0/18:1(n-9) |
| 17.592 (1.8222) | GalCer d18:1/24:0 |
| 11.461 (1.9487) | GalCer d18:1/24:1(n-9)hydroxy |
| 9.602 (0.8445) | SM dl 8:1/24:1(n-9) |
| 9.106 (0.1234) | PE C18:1p/18:1 // (n-6)(31%),(n-9)(69%) |
| 8.340 (1.5634) | PC16:0/18:1(n-6) |
| 7.683 (1.5133) | PC 18:0/20:4(n-6,n-9,n-12,n-15) |
| 7.131 (0.5844) | PE18:0/20:4(n-6,n-9,n-12,n-15) |
| 6.648 (1.2463) | PC16:0/18:1(n-12) |
| 6.267 (1.1768) | PS18:0/18:1(n-9) |
| 5.876 (0.7032) | GalCer d18:1/24:1(n-7)hydroxy |
| 5.633 (0.6354) | PC18:0/20:1(n-9) |
| 5.510 (0.1857) | GalCer d18:1/18:0 |
| 5.364 (1.0056) | PC18:1/16:0(n-9) |
| 5.306 (0.1378) | PE18:0/22:6(n-3,n-6,n-9,n-12,n-15,n-18) |
| 5.186 (0.9367) | PC18:0/18:1(n-15) |
| 5.178 (0.5065) | PE C18p/22:6(n-3,n-6,n-9,n-12,n-15,n-18) |
| 4.485 (0.8393) | PC18:0/18:1(n-6) |
| 4.472 (0.7396) | PC18:1/18:1 // (n-3)(14%),(n-6)(34%),(n-9)(52%) |
| 3.594 (0.4785) | PC16:0/22:6(n-3,n-6,n-9,n-12,n-15,n-18) |
| 3.566 (0.0903) | PE C18p/18:1(n-9) |
| 3.437 (0.5382) | PE17:2(n-6,n-9)/20:4(n-6,n-9,n-12,n-15) |
| 3.347 (0.6046) | PC18:0/18:1(n-3) |
| 3.326 (0.1797) | PE C18p/22:4(n-6,n-9,n-12,n-15) |
| 3.233 (0.1124) | PE C18:1p/22:4(n-6,n-9,n-12,n-15) |
| 3.164 (0.2661) | PE C16p/18:1(n-9) |
| 3.065 (0.4135) | DAG_20:4(n-6,n-9,n-12,n-15)_18:0 |
| 2.975 (0.0970) | SM d 18:1/22:0 |
| 2.696 (0.0748) | SM d20:1/18:0 |
| 2.680 (0.2582) | GalCer d18:1/21:1(n-9)hydroxy |
| 2.510 (0.2206) | SM d18:1/24:1(n-3) |
| 2.391 (0.2698) | PC18:0,20:1(n-6) |
| 2.340 (0.0867) | PE18:1/18:1(n-9) |
| 2.334 (0.1347) | PE C18:1p/20:1 // (n-6)(5%),(n-7)(18%),(n-9)(77%) |
| 2.314 (0.5030) | PC C16p/18:0 |
| 2.286 (0.0749) | PE 18:0/22:4(n-9,n-12,n-15,n-18) |
| 2.237 (0.2173) | Cer d18:1/18:0 |
| 2.230 (0.0696) | Ga1Cer d18:1/23:0 |
| 2.170 (0.2764) | PC 18;1(n-7)/20:4(n-3,n-6,n-9,n-12) |
| 2.162 (0.1824) | GalCer d18:1/21:2 hydroxy |
| 2.098 (0.2517) | PC18:0/22:6(n-3,n-6,n-9,n-12,n-15,n-18)) |
| 2.051 (0.1309) | PE C16p/20:4(n-6,n-9,n-12,n-15) |
| 1.877 (0.2764) | PC18:1 (n-3)/20:4(n-3,n-6,n-9,n-12) |
| 1.839 (0.2879) | PE 17:2 (n-9,n-12)/20:4(n-6,n-9,n-12,n-15) |
| 1.802 (0.0498) | SM d18:1/20:0 |
| 1.802 (0.3268) | PI18:0/20:4(n-6, n-9,n-12, n-15) |
| 1.721 (0.1607) | GalCer d18:1/26:1(n-7)hydroxy |
| 1.715 (0.1647) | GalCer d18:1/21:1(n-6)hydroxy |
| 1.714 (0.1443) | PE C18:1p/16:0(n-9) |
| 1.550 (0.0678) | GalCer d18:1/20:0 |
| 1.497 (0.0501) | GalCer d18:1/22:1(n-7)hydroxy |
| 1.490 (0.0230) | GalCer d18:1/24:2(n-6,n-9) |
| 1.424 (0.0986) | GalCer d18:1/26:1(n-9)hydroxy |
| 1.404 (0.0973) | GalCer d18:1/26:1 hydroxy |
| 1.394 (0.1670) | GalCer d18:1/24:1 (n-3)hydroxy |
| 1.349 (0.2784) | PS18:1/18:1 // (n-6)(35%),(n-9)(64%),(n-12)(1%) |
| 1.297 (0.1463) | PC18:0/20:1(n-3) |
| 1.275 (0.0676) | GalCer d18:1/25:1 (n-9) |
| 1.275 (0.1518) | PC C18:1p/18:1 // (n-3)(46%),(n-9)(54%) |
| 1.262 (0.0708) | PE C16p/22:6(n-3,n-6,n-9,n-12,n-15,n-18) |
| 1.213 (0.0306) | PE C16p/20:1(n-9) |
| 1.192 (0.1226) | PC16:0/16:1(n-12) |
| 1.178 (0.1211) | PC16:0/16:1(n-9) |
| 1.173 (0.2764) | PC18:1(n-8)/20:4(n-3,n-6,n-9,n-12) |
Concentration in this table represents the weight in milligrams in 1 g of the total lipid extract. The full list appears in supplemental Table S3.